Senior Financial Analyst/Finance Manager

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC‑6236), a RAS(ON) multi‑selective inhibitor; elironrasib (RMC‑6291), a RAS(ON) G12C‑selective inhibitor; zoldonrasib (RMC‑9805), a RAS(ON) G12D‑selective inhibitor; and RMC‑5127, a RAS(ON) G12V‑selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity Revolution Medicines is seeking a Sr. Financial Analyst/Finance Manager to support our growing needs in Development and R&D Finance. The successful candidate will have experience with clinical trials, R&D accruals process, month‑end close, financial reporting, SOX, and audit support. This position is based out of our headquarters in Redwood City, CA. Reporting to the Associate Director, FP&A and will serve as a business partner to Clinical Operations and cross‑functional partner to Accounting, Finance, and Procurement. Prepare month‑end clinical trial accruals, including review of CRO reports, patient costs, and site payments. Prepare monthly and quarterly reconciliations for accrued clinical and related prepaid accounts. Contribute to Identify, design, and implement process improvements to streamline clinical trial accruals, reducing manual effort and improving accuracy and timeliness. Review contracts and amendments to analyze and determine impact on clinical accruals. Prepare contract analysis to assess new contracts against existing budget. Work with external CROs and vendors to ensure that expenses are accurately accounted for. Ensure and maintain proper documentation and internal controls around clinical trial accruals for SOX compliance. Partner with the accounting team to support monthly and quarterly close activities. Support the annual audit and quarterly reviews through preparation of audit schedules and other documentation as requested by external auditors. Perform variance analysis of actuals versus budget, investigate and explain key discrepancies, and identify underlying business drivers. Prepare actuals vs budget dashboard monthly to provide financial visibility to business partners. Review purchase requests against budgeted amount and account coding. Prepare ad hoc financial analysis and special projects as needed. Required Skills, Experience and Education Bachelor's degree in finance, Accounting, or related field. 4+ years’ experience in a similar role in biotechnology industry. Experience in reviewing clinical contracts (i.e. CRO contracts, Site contracts, protocols, etc.). Highly proficient in Excel and strong attention to detail. Prior ERP and financial systems experience: Netsuite, etc. Strong work ethic and ability to adjust workload based on changing priorities. Preferred Skills CPA or MBA. Biotech or Big 4 Accounting experience. Prior experience with clinical trial accruals. Adaptive Planning (Office Connect) experience a plus. Coupa experience a plus. Base Pay Salary Range Base Pay Salary Range: $120,000 - $150,000 USD Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status. #J-18808-Ljbffr Revolution Medicines